UCB S.A.

| -5.87% | O: 0.14% H: 0.0% C: -0.0%
SNYNF | News | $92.7 600K

| -3.13% | O: 0.26% H: 1.36% C: 1.36%
AZNCF | $138.24 800

| 6.54% | O: -0.85% H: 1.12% C: 0.43%
NVSEF | $93.6375 6.88% 82K

| -8.14% | O: 0.92% H: 0.0% C: 0.0%
UCBJY | $63.676 7.2K

| 25.87% | O: 1.46% H: 0.44% C: 0.44%
ALPMY | $9.47 520K

| -16.01% | O: -0.27% H: 0.0% C: -1.17%
TAK | News | $13.19 0.23% 740K

| -10.79% | O: -0.2% H: 0.14% C: -0.48%
NVS | $94.285 1.85% 1.6M

| -9.24% | O: -0.06% H: 0.46% C: 0.29%
GSK | $39.585 0.8% 1.1M

| -5.58% | O: -0.69% H: 1.42% C: 1.22%
LLY | $727.48 -2.48% 2M

| 0.65% | O: 2.37% H: 1.51% C: 0.79%
BMY | $48.89 1.22% 5.1M

| -5.13% | O: -0.65% H: 1.63% C: 1.48%
ABBV | News | $165.97 0.8% 3.1M

| -6.33% | O: -0.88% H: 1.46% C: 1.13%
SNY | News | $46.545 2.55% 2.3M

| -3.44% | O: 1.67% H: 0.0% C: 0.0%
AZN | $68.41 0.07% 2.9M

| 4.88% | O: -2.81% H: 2.08% C: 1.38%
AMGN | $267.41 1.77% 1.4M

| -6.54% | O: -0.35% H: 1.15% C: 0.96%
lung reach cancer cell diagnostics therapy market

Blood Cancer Drugs Market Report 2023: Reveals Striking Growth Prospects with a Surge in R&D Activities - Long-term Forecasts to 2028 and 2033
Published: 2024-02-06 (Crawled : 00:00) - prnewswire.com
ALPMF | $9.17 16K

| -13.72% | O: -1.53% H: 0.0% C: 0.0%
AZNCF | $138.24 800

| 1.09% | O: -0.37% H: 0.0% C: 0.0%
NVSEF | $93.6375 6.88% 82K

| -8.98% | O: 0.41% H: 0.0% C: 0.0%
UCBJY | $63.676 7.2K

| 37.02% | O: 1.71% H: 1.28% C: 0.94%
ALPMY | $9.47 520K

| -14.23% | O: 0.28% H: 0.18% C: 0.0%
TAK | News | $13.19 0.23% 740K

| -7.13% | O: 0.07% H: 0.42% C: 0.07%
NVS | $94.285 1.85% 1.6M

| -10.28% | O: 0.09% H: 0.39% C: -0.36%
JNJ | News | $147.895 1.48% 5.8M

| -6.93% | O: 1.47% H: 0.0% C: 0.0%
LLY | $727.48 -2.48% 2M

| 6.49% | O: 0.76% H: 4.31% C: 2.11%
BMY | $48.89 1.22% 5.1M

| -1.95% | O: -0.14% H: 0.35% C: -1.12%
ABBV | News | $165.97 0.8% 3.1M

| -3.43% | O: 1.48% H: 0.0% C: 0.0%
VRTX | News | $395.0 0.39% 550K

| -5.09% | O: 0.15% H: 2.4% C: 0.56%
SNY | News | $46.545 2.55% 2.3M

| -2.19% | O: 1.33% H: 0.0% C: 0.0%
JAZZ | $110.6 1.22% 210K

| -14.12% | O: -0.02% H: 0.0% C: -1.4%
AZN | $68.41 0.07% 2.9M

| 1.83% | O: -0.4% H: 0.19% C: -0.33%
AMGN | $267.41 1.77% 1.4M

| -16.18% | O: -0.18% H: 0.0% C: -6.22%
report cancer blood growth market

Chronic Inflammatory Demyelinating Polyneuropathy Market to Register Positive Growth During the Study Period (2019-2032), Evaluates DelveInsight | Key Companies to Watch Out - Octapharma, argenx, Immunovant Sciences, Sanofi, Janssen, Takeda
Published: 2023-12-12 (Crawled : 22:00) - prnewswire.com
SNYNF | News | $92.7 600K

| -1.13% | O: -0.06% H: 2.36% C: 2.36%
UCBJY | $63.676 7.2K

| 53.09% | O: -0.62% H: 1.01% C: 1.01%
JNJ | News | $147.895 1.48% 5.8M

| -6.39% | O: -0.71% H: 0.0% C: 0.0%
SNY | News | $46.545 2.55% 2.3M

| -4.01% | O: -0.27% H: 2.28% C: 2.16%
CPRX | $15.3 -0.26% 1.3M

| 16.4% | O: -0.37% H: 5.49% C: 5.49%
companies positive growth study market

Key Players Such as AbbVie, Roche, and Amgen Dominate the Competitive Landscape of the Expanding Cytokine Market
Published: 2023-11-03 (Crawled : 01:00) - prnewswire.com
UCBJF | $126.05 100

| 67.95% | O: -1.4% H: 0.0% C: 0.0%
UCBJY | $63.676 7.2K

| 74.86% | O: 0.48% H: 1.02% C: 0.42%
TMO | News | $543.895 0.44% 830K

| 19.94% | O: 2.32% H: 0.0% C: 0.0%
ABBV | News | $165.97 0.8% 3.1M

| 16.94% | O: 1.88% H: 0.0% C: 0.0%
TECH | $62.51 0.48% 350K

| 13.21% | O: 2.71% H: 4.38% C: 3.18%
AMGN | $267.41 1.77% 1.4M

| -0.62% | O: 0.72% H: 0.76% C: 0.5%
ABCM | $23.99 0.0% 7.4M

| 3.63% | O: 0.0% H: 0.0% C: 0.0%
market

Leading Players Pfizer, AbbVie, and Novartis at the Forefront of Advancements in Plaque Psoriasis Treatment
Published: 2023-09-20 (Crawled : 22:00) - prnewswire.com
UCBJY | $63.676 7.2K

| 41.78% | O: -0.79% H: 0.0% C: -1.26%
NVS | $94.285 1.85% 1.6M

| -10.14% | O: -0.7% H: 0.06% C: -0.75%
LLY | $727.48 -2.48% 2M

| 30.85% | O: -1.47% H: 0.0% C: 0.0%
ABBV | News | $165.97 0.8% 3.1M

| 7.43% | O: -0.04% H: 0.76% C: -0.16%
SNY | News | $46.545 2.55% 2.3M

| -17.87% | O: -1.16% H: 0.0% C: 0.0%
AMGN | $267.41 1.77% 1.4M

| -2.4% | O: 0.22% H: 0.15% C: -0.98%
psoriasis treatment novartis

Global CNS Therapeutics Strategic Business Report 2023: Burgeoning Global Aging Populace, Longer Life Expectancy to Drive CNS Demand
Published: 2023-06-30 (Crawled : 23:00) - prnewswire.com
ALKS | $23.735 -0.11% 620K

| Email alert Add to watchlist
AZN | $68.41 0.07% 2.9M

| Email alert Add to watchlist
NBIX M | $130.31 -1.68% 260K

| Email alert Add to watchlist
SNY | News | $46.545 2.55% 2.3M

| Email alert Add to watchlist
ABBV | News | $165.97 0.8% 3.1M

| Email alert Add to watchlist
BMY | $48.89 1.22% 5.1M

| Email alert Add to watchlist
LLY | $727.48 -2.48% 2M

| Email alert Add to watchlist
JNJ | News | $147.895 1.48% 5.8M

| Email alert Add to watchlist
NVS | $94.285 1.85% 1.6M

| Email alert Add to watchlist
PFE A | $25.91 2.05% 22M

| Email alert Add to watchlist
TAK | News | $13.19 0.23% 740K

| Email alert Add to watchlist
UCBJY | $63.676 7.2K

| Email alert Add to watchlist
NVSEF | $93.6375 6.88% 82K

| Email alert Add to watchlist
AZNCF | $138.24 800

| Email alert Add to watchlist
SNYNF | News | $92.7 600K

| Email alert Add to watchlist
UCBJF | $126.05 100

| Email alert Add to watchlist
TEVJF | $12.37 -24.22% 380

| Email alert Add to watchlist
report business life global therapeutics

Global Axial Spondyloarthritis Treatment Market to 2027: Increase in the Number of Approved Biosimilars Fuels the Sector
Published: 2023-06-16 (Crawled : 02:00) - prnewswire.com
UCBJY | $63.676 7.2K

| 37.7% | O: 1.21% H: 0.0% C: -0.2%
PFE A | $25.91 2.05% 22M

| -36.05% | O: 0.28% H: 1.25% C: 0.5%
JNJ | News | $147.895 1.48% 5.8M

| -11.47% | O: 0.46% H: 0.31% C: -0.15%
LLY | $727.48 -2.48% 2M

| 65.39% | O: 0.41% H: 0.26% C: -1.77%
BMY | $48.89 1.22% 5.1M

| -25.31% | O: 0.32% H: 2.1% C: 1.97%
approved treatment global market

Global Acute Repetitive Seizures Market to Showcase Promising Growth says Brandessence Market Research
Published: 2023-05-15 (Crawled : 10:00) - prnewswire.com
UCBJY | $63.676 7.2K

| 38.83% | O: 1.79% H: 0.18% C: -0.06%
TAK | News | $13.19 0.23% 740K

| -19.72% | O: 0.61% H: 0.3% C: 0.24%
JNJ | News | $147.895 1.48% 5.8M

| -9.85% | O: 0.01% H: 0.14% C: -0.78%
LLY | $727.48 -2.48% 2M

| 72.82% | O: 0.22% H: 0.14% C: -0.2%
ABBV | News | $165.97 0.8% 3.1M

| 12.24% | O: 0.35% H: 0.83% C: -0.73%
VRTX | News | $395.0 0.39% 550K

| 13.69% | O: 0.17% H: 1.07% C: 0.19%
SNY | News | $46.545 2.55% 2.3M

| -15.86% | O: 0.38% H: 0.0% C: 0.0%
GILD | News | $66.45 0.44% 4.3M

| -14.42% | O: -0.13% H: 0.42% C: 0.4%
research global growth market

The Galien Foundation Announces 2023 Prix Galien UK Award Candidates for "Best Biotechnology Product," "Best Digital Health Solution," "Best Medical Technology," "Best Pharmaceutical Product" and Newly Added, "Best Public Sector Innovation"
Published: 2023-05-02 (Crawled : 08:00) - prnewswire.com
SNYNF | News | $92.7 600K

| -16.73% | O: -5.0% H: 1.66% C: 1.66%
UCBJY | $63.676 7.2K

| 37.17% | O: -1.18% H: 0.43% C: 0.43%
SNY | News | $46.545 2.55% 2.3M

| -15.57% | O: -0.94% H: 0.0% C: 0.0%
award health medical

Global Best Selling Pharmaceutical Drugs Analysis Report 2023: Revenue Forecast of the Top 50 Pharmaceutical Drugs and Assessment of their Regulatory Landscape through 2021
Published: 2023-03-10 (Crawled : 20:00) - prnewswire.com
AMGN | $267.41 1.77% 1.4M

| Email alert Add to watchlist
ENDP | $0.2926 -9.6%

| Email alert Add to watchlist
SNY | News | $46.545 2.55% 2.3M

| Email alert Add to watchlist
ABBV | News | $165.97 0.8% 3.1M

| Email alert Add to watchlist
BHC | $8.63 0.35% 2.1M

| Email alert Add to watchlist
GSK | $39.585 0.8% 1.1M

| Email alert Add to watchlist
JNJ | News | $147.895 1.48% 5.8M

| Email alert Add to watchlist
NVS | $94.285 1.85% 1.6M

| Email alert Add to watchlist
NVO | $122.69 -0.05% 3.8M

| Email alert Add to watchlist
VTRS | $11.21 0.81% 2.4M

| Email alert Add to watchlist
ALPMY | $9.47 520K

| Email alert Add to watchlist
UCBJY | $63.676 7.2K

| Email alert Add to watchlist
MNKKQ | $0.02

| Email alert Add to watchlist
NVSEF | $93.6375 6.88% 82K

| Email alert Add to watchlist
SNYNF | News | $92.7 600K

| Email alert Add to watchlist
GLAXF | $20.2 510

| Email alert Add to watchlist
ALPMF | $9.17 16K

| Email alert Add to watchlist
UCBJF | $126.05 100

| Email alert Add to watchlist
TEVJF | $12.37 -24.22% 380

| Email alert Add to watchlist
MNK | $0.3402 -0.06% 540K

| Email alert Add to watchlist
CSLLY | $86.918 60K

| Email alert Add to watchlist
MNKPF | $17.25

| Email alert Add to watchlist
CMXHF | $172.54 50

| Email alert Add to watchlist
ENDPQ | $0.0006 3.4K

| Email alert Add to watchlist
global report

See all

Last 15 days Sec forms

File Id

Form

Published Date

Transaction Date

Direction

Code

Amount Transacted

Owned Amount

Your Today's Watch List

Gainers vs Losers

71%

29%

Top 10 Gainers

AGBA | News | $1.305 226.25% 130M

EGOX | $0.0503 39.72% 320M

RWOD | $10.52 31.56% 5.9M

ZCMD | $1.905 31.38% 30M

Commercial Services

MRDB 4 | $0.536 27.65% 2M

BSFC | $0.0822 27.64% 75M

TPET | $0.4121 25.68% 45M

NVFY | $2.65 25.59% 33M

Consumer Durables

INDO | $5.1 25.0% 15M

Energy Minerals

CHRO | $1.53 24.9% 100K

Last 48 Hours Insiders Buying

CLSD | $1.42 7.58% 170K

| 14:00
CDZI P 25000 | $2.255 0.22% 160K

Utilities

| 14:00
ETST P 39000 | $0.068 43K

| 13:30
FNLC P 1275 | $22.91 3.38% 13K

| 12:30
ADMQ | $0.0532 480K

| 10:30
AXR P 2400 | $20.99 -5.32% 11K

| 21:00
QCRH P 118 | $56.88 2.65% 23K